Jan 11, 2021 / 03:00PM GMT
Cory William Kasimov - JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst
All right. Good morning from the virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company, Biogen, and CEO Michel Vounatsos.
Please note that following this presentation, we will have a Q&A session right here in this Zoom room where you'll also be able to submit your questions via the little blue Ask A Question button in your conference portal. So with that, Michel, thanks for being here today, and let me turn things over to you.
Michel Vounatsos - Biogen Inc. - CEO & Director
Thank you, Cory. Good day, everyone, and thank you for joining the Biogen session. I would like to point out that we'll be making some forward-looking statements, which are based on our expectation and beliefs. These statements are subject to risks and uncertainties. So therefore, I encourage you to consult the risk factors discussed in our SEC filing.
I would like to
Biogen Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers